Pietzak, E. J., Ballman, K. V., Dooley, K., Clark, A., Ngo, Z., Carvalho, F. D., Sundi, D., Correa, A. F., Delacroix, S. E., Kates, M. R., Westerman, M. E., O'Malley, P., Tan, A., Berg, S. A., Woods, M., Galsky, M. D., Rosenberg, J. E. (2026). The GAIN trial: Gemcitabine alternating with intravesical BCG randomized against BCG alone for patients with recurrent “BCG-exposed” high-grade non-muscle invasive bladder cancer (NMIBC) (ALLIANCE A032303).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps909